Lynx1 Capital Management LP Passage Bio, Inc. Transaction History
Lynx1 Capital Management LP
- $279 Million
- Q3 2024
A detailed history of Lynx1 Capital Management LP transactions in Passage Bio, Inc. stock. As of the latest transaction made, Lynx1 Capital Management LP holds 8,426,955 shares of PASG stock, worth $4.97 Million. This represents 2.11% of its overall portfolio holdings.
Number of Shares
8,426,955Holding current value
$4.97 Million% of portfolio
2.11%Shares
11 transactions
Others Institutions Holding PASG
# of Institutions
46Shares Held
38.7MCall Options Held
7.7KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA9.82MShares$5.8 Million0.16% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$3.6 Million0.32% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$1.47 Million1.8% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$1.45 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$1.22 Million0.0% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $32.1M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...